HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparative effects of the alpha7 nicotinic partial agonist, S 24795, and the cholinesterase inhibitor, donepezil, against aging-related deficits in declarative and working memory in mice.

AbstractINTRODUCTION:
The comparative effects of a newly described specific alpha7 nAChR partial agonist, S 24795, and a cholinesterase inhibitor, donepezil, currently used as a symptomatic Alzheimer's disease treatment were studied in two mouse models of aging-related memory deficits.
MATERIALS AND METHODS:
We employed radial arm-maze paradigms assessing short-term working memory (STWM, experiment A) and mnemonic flexibility, a cardinal property of long-term declarative (LTDM, experiment B). Both compounds were administered daily at 0.3 and 1 mg/kg subcutaneously (~3 weeks).
RESULTS:
In the STWM experiment, vehicle-treated aged mice displayed a severe and persistent deficit in the retention of successive arm visits in comparison to younger controls. S 24795 at 1 mg/kg (trends at 0.3 mg/kg) and donepezil at 0.3 mg/kg (but not 1 mg/kg) exerted beneficial effects on this deficit: The performance of aged mice treated with these drugs remarkably increased across the testing days and almost reached young adult performance level. In the critical test trials of memory flexibility (i.e., LTDM), in experiment B, S 24795 at 1 mg/kg (trends at 0.3 mg/kg) and donepezil at the dose of 1 mg/kg (but not 0.3 mg/kg) improved aged mice performance.
CONCLUSION:
This preclinical demonstration that S 24795 restored specific age-related memory deficits with as much efficacy as donepezil adds to recent literature in highlighting the potential interest of an alpha7 nAChR drug as a symptomatic AD therapeutic.
AuthorsA Marighetto, S Valerio, A Desmedt, J N Philippin, C Trocmé-Thibierge, P Morain
JournalPsychopharmacology (Psychopharmacology (Berl)) Vol. 197 Issue 3 Pg. 499-508 (Apr 2008) ISSN: 0033-3158 [Print] Germany
PMID18265960 (Publication Type: Journal Article)
Chemical References
  • Cholinesterase Inhibitors
  • Chrna7 protein, mouse
  • Indans
  • Nicotinic Agonists
  • Nootropic Agents
  • Piperidines
  • Pyridinium Compounds
  • Receptors, Nicotinic
  • S 24795
  • alpha7 Nicotinic Acetylcholine Receptor
  • Donepezil
Topics
  • Aging (drug effects)
  • Alzheimer Disease (psychology)
  • Animals
  • Choice Behavior (drug effects)
  • Cholinesterase Inhibitors (pharmacology)
  • Discrimination Learning (drug effects)
  • Disease Models, Animal
  • Donepezil
  • Dose-Response Relationship, Drug
  • Indans (pharmacology)
  • Inhibition, Psychological
  • Injections, Subcutaneous
  • Maze Learning (drug effects)
  • Memory, Short-Term (drug effects)
  • Mice
  • Mice, Inbred C57BL
  • Nicotinic Agonists (pharmacology)
  • Nootropic Agents (pharmacology)
  • Piperidines (pharmacology)
  • Pyridinium Compounds (pharmacology)
  • Receptors, Nicotinic (drug effects)
  • Retention, Psychology (drug effects)
  • alpha7 Nicotinic Acetylcholine Receptor

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: